Literature DB >> 10761702

Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas.

Z Q Yang1, M A Yoshida, Y Fukuda, N Kurihara, Y Nakamura, J Inazawa.   

Abstract

Comparative genomic hybridization (CGH) was used to screen for genomic imbalances in cell lines derived from 13 nonpapillary renal-cell carcinomas (RCCs), two papillary RCCs, one renal squamous-cell carcinoma, and one transitional-cell carcinoma of the renal pelvis. Aberrations were found in all 17 lines. The most frequent changes in nonpapillary RCC cell lines were gains of 5q (85%), 7q (69%), 8q (69%) and 1q (54%) and losses of 3p (92%), 8p (77%), 4q (62%) and 14q (54%). High-level gains (HLGs) were detected at 4q12, 5p, 5q23-33, 7q22-qter, 8q23-24, 10q21-qter, 12p and 12q13-22. By means of fluorescence in situ hybridization (FISH) we narrowed the smallest common region involving 5q gains to the genomic segment between D5S642 and D5S673, and found that the HLG at 4q12 possibly involved amplifications of c-kit and PDGFRA. Two papillary RCC cell lines showed gains of entire chromosomes 7, 12 and 17. The CGH data reported here should help to facilitate the choice of individual renal-tumor cell lines for exploring target genes in regions of interest.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761702      PMCID: PMC5926323          DOI: 10.1111/j.1349-7006.2000.tb00927.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  31 in total

1.  Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization.

Authors:  T Sakabe; T Shinomiya; T Mori; Y Ariyama; Y Fukuda; T Fujiwara; Y Nakamura; J Inazawa
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

2.  Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.

Authors:  J Gronwald; S Störkel; H Holtgreve-Grez; P Hadaczek; C Brinkschmidt; A Jauch; J Lubinski; T Cremer
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

3.  Allelotype of renal cell carcinoma.

Authors:  R Morita; J Ishikawa; M Tsutsumi; K Hikiji; Y Tsukada; S Kamidono; S Maeda; Y Nakamura
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

4.  Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia.

Authors:  T Ariyama; J Inazawa; Y Uemura; N Kakazu; T Maekawa; F Urase; K Irimajiri; A Horiuchi; Y Nakamura; T Abe
Journal:  Cancer Genet Cytogenet       Date:  1995-05

5.  Computer image analysis of comparative genomic hybridization.

Authors:  J Piper; D Rutovitz; D Sudar; A Kallioniemi; O P Kallioniemi; F M Waldman; J W Gray; D Pinkel
Journal:  Cytometry       Date:  1995-01-01

6.  Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization.

Authors:  M Bentz; U S Bergerheim; C Li; S Joos; C A Werner; M Baudis; J Gnarra; M J Merino; B Zbar; W M Linehan; P Lichter
Journal:  Cytogenet Cell Genet       Date:  1996

7.  Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas.

Authors:  C Kenck; P Bugert; M Wilhelm; G Kovacs
Journal:  Oncogene       Date:  1997-03-06       Impact factor: 9.867

8.  Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation.

Authors:  F Jiang; H Moch; J Richter; C Egenter; T Gasser; L Bubendorf; R Gschwind; G Sauter; M J Mihatsch
Journal:  J Pathol       Date:  1998-08       Impact factor: 7.996

9.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

10.  Rearrangements of chromosome 3 in nonfamilial renal cell carcinomas from Japanese patients.

Authors:  M A Yoshida; T Ikeuchi; Y Tachibana; K Takagi; M Moriyama; A Tonomura
Journal:  Jpn J Cancer Res       Date:  1988-05
View more
  5 in total

1.  Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  F B F Law; Y W Chen; K Y Wong; J Ying; Q Tao; C Langford; P Y Lee; S Law; R W L Cheung; C H Chui; S W Tsao; K Y Lam; J Wong; G Srivastava; J C O Tang
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

2.  Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering.

Authors:  Satoshi Abe; Hiromi Tanaka; Tomomi Notsu; Shin-Ichi Horike; Chikako Fujisaki; Dong-Lai Qi; Takahito Ohhira; David Gilley; Mitsuo Oshimura; Hiroyuki Kugoh
Journal:  Genome Integr       Date:  2010-05-26

3.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

4.  Development of a New Monochrome Multiplex qPCR Method for Relative Telomere Length Measurement in Cancer.

Authors:  Paige N Dahlgren; Kanokwan Bishop; Shatovisha Dey; Brittney-Shea Herbert; Hiromi Tanaka
Journal:  Neoplasia       Date:  2018-03-21       Impact factor: 5.715

5.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.

Authors:  Thomas J Mitchell; Samra Turajlic; Andrew Rowan; David Nicol; James H R Farmery; Tim O'Brien; Inigo Martincorena; Patrick Tarpey; Nicos Angelopoulos; Lucy R Yates; Adam P Butler; Keiran Raine; Grant D Stewart; Ben Challacombe; Archana Fernando; Jose I Lopez; Steve Hazell; Ashish Chandra; Simon Chowdhury; Sarah Rudman; Aspasia Soultati; Gordon Stamp; Nicos Fotiadis; Lisa Pickering; Lewis Au; Lavinia Spain; Joanna Lynch; Mark Stares; Jon Teague; Francesco Maura; David C Wedge; Stuart Horswell; Tim Chambers; Kevin Litchfield; Hang Xu; Aengus Stewart; Reza Elaidi; Stéphane Oudard; Nicholas McGranahan; Istvan Csabai; Martin Gore; P Andrew Futreal; James Larkin; Andy G Lynch; Zoltan Szallasi; Charles Swanton; Peter J Campbell
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.